Literature DB >> 21484925

Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy.

Ivan Marcelo Gonçalves Agra1, Alfio Ferlito, Robert P Takes, Carl E Silver, Kerry D Olsen, Sandro J Stoeckli, Primož Strojan, Juan P Rodrigo, João Gonçalves Filho, Eric M Genden, Missak Haigentz, Avi Khafif, Randal S Weber, Peter Zbären, Carlos Suárez, Dana M Hartl, Alessandra Rinaldo, Kwang Hyun Kim, Luiz P Kowalski.   

Abstract

Surgery is the preferred modality for curative treatment of recurrent laryngeal cancer after failure of nonsurgical treatments. Patients with initial early-stage cancer experiencing recurrence following radiotherapy often have more advanced-stage tumors by the time the recurrence is recognized. About one third of such recurrent cancers are suitable for conservation surgery. Endoscopic resection with the CO(2) laser or open partial laryngectomy (partial vertical, supracricoid, or supraglottic laryngectomies) have been used. The outcomes of conservation surgery appear better than those after total laryngectomy, because of selection bias. Transoral laser surgery is currently used more frequently than open partial laryngectomy for treatment of early-stage recurrence, with outcomes equivalent to open surgery but with less associated morbidity. Laser surgery has also been employed for selective cases of advanced recurrent disease, but patient selection and expertise are required for application of this modality to rT3 tumors. In general, conservation laryngeal surgery is a safe and effective treatment for localized recurrences after radiotherapy for early-stage glottic cancer. Recurrent advanced-stage cancers should generally be treated by total laryngectomy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21484925     DOI: 10.1002/hed.21739

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  20 in total

1.  Advanced and rapidly progressing head and neck cancer: good palliation following intralesional bleomycin.

Authors:  Keith Ian Quintyne; Shirley Baker; Fintan Wallis; Neville Shine; Rajnish Gupta
Journal:  BMJ Case Rep       Date:  2011-09-19

2.  Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study.

Authors:  Peijing Li; Weihan Hu; Yuan Zhu; Jianjiang Liu
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

3.  Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Authors:  Pei-Jing Li; Wei-Han Hu; Ting Jin
Journal:  Mol Clin Oncol       Date:  2015-10-29

4.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

5.  Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Authors:  Peter Zbären; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503

6.  Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.

Authors:  Vlad C Sandulache; Laura J Vandelaar; Heath D Skinner; Juan Cata; Katherine Hutcheson; Clifton David Fuller; Jack Phan; Zuhair Siddiqui; Stephen Y Lai; Randal S Weber; Mark E Zafereo
Journal:  Head Neck       Date:  2016-02-16       Impact factor: 3.147

7.  Indications and results of extended total laryngectomy with en-bloc resection of overlying cervical skin.

Authors:  Xavier León; Montserrat López; Jacinto García; Maria Casasayas; Carlota Rovira; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-26       Impact factor: 2.503

8.  Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.

Authors:  William M Mendenhall; Robert P Takes; Jatin P Shah; Patrick J Bradley; Jonathan J Beitler; Primož Strojan; Carlos Suárez; Juan P Rodrigo; Nabil F Saba; Alessandra Rinaldo; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-08       Impact factor: 2.503

9.  Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Authors:  Janice L Farlow; Andrew C Birkeland; Andrew J Rosko; Kyle VanKoevering; Catherine T Haring; Joshua D Smith; J Chad Brenner; Andrew G Shuman; Steven B Chinn; Chaz L Stucken; Kelly M Malloy; Jeffrey S Moyer; Keith A Casper; Scott A McLean; Mark E P Prince; Carol R Bradford; Gregory T Wolf; Douglas B Chepeha; Matthew E Spector
Journal:  Ann Surg Oncol       Date:  2019-03-04       Impact factor: 5.344

10.  Surgical options in radiotherapy-failed early glottic cancer.

Authors:  Roberto Santoro; Giuseppe Meccariello; Giuditta Mannelli; Belinda Bini; Fabiola Paiar; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.